Skip to main navigation Skip to search Skip to main content

S5 Sustained Improvements in Health-Related Quality of Life Outcomes With Long-Term Risankizumab Treatment in Patients With Moderately to Severely Active Crohns Disease: Results from the FORTIFY Open-Label, Long-Term Extension

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAmerican Journal of Gastroenterology
DOIs
Publication statusPublished - 2024

Keywords

  • Medicine
  • Crohns disease
  • Quality of life (healthcare)
  • Term (time)
  • Disease
  • Crohn disease
  • Intensive care medicine
  • Physical therapy
  • Internal medicine
  • Physics
  • Nursing
  • Quantum mechanics

Cite this